MIRALOCK
LIVE

Serial Number

99605203

Owner

Mirador Therapeutics, Inc.

Attorney

Brent D. Sokol

Filing Date

Jan 20, 2026

Add to watchlist:

No watchlists yet
View on USPTO

MIRALOCK Trademark

Serial Number: 99605203

MIRALOCK is a trademark filed by Mirador Therapeutics, Inc. on January 20, 2026. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Mirador Therapeutics, Inc. (8 trademarks)

3115 Merryfield Row, Suite 210
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

January 20, 2026

Registration Date

Not Registered

Published for Opposition

June 16, 2026

Goods & Services

Research, development and consultation related thereto in the medical, pharmaceutical research and biotechnology fields; Pharmaceutical research and development of pharmaceutical preparations; Research and development services in the fields of human and animal pharmaceutical and biotechnology drug development and manufacture; Laboratory research services in connection with developing new medicinal products; Scientific research, development and consultation services in the fields of immunology, antibodies, vaccines, medicine, biotherapeutics, and therapeutics

Pharmaceutical preparations for the diagnosis, prevention, or treatment of inflammation and immunology disorders or diseases, autoimmune diseases, cancer, and other diseases of the immune systems, digestive systems, skin, joint, lung, liver, kidney, bile duct, nervous systems, or gastrointestinal systems; Diagnostic preparations for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing; Chemical, biological and biochemical reagents for medical or veterinary purposes; Diagnostic test kits comprised of medical diagnostic reagents and assays that test for the presence of antigens, pathogens, biomarkers for diseases, or biomarkers for predicting patients' response to therapeutic agents

Chemical substances, chemical materials and chemical preparations for scientific purposes; Active pharmaceutical ingredients, namely, antibodies, proteins and small molecules for use in the manufacture of pharmaceuticals, biopharmaceuticals, vaccines, and finished drug products for the diagnosis, prevention, or treatment of inflammation and immunology disorders or diseases, autoimmune diseases, cancer, and other diseases of the immune systems, digestive systems, skin, joint, lung, liver, kidney, bile duct, nervous systems, or gastrointestinal systems; Antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 16, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jun 16, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 10, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 19, 2026 CNSA
ASSIGNED TO EXAMINER
May 18, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 9, 2026 NWOS
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 2, 2026 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 2, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 2, 2026 COAR
APPLICATION FILING RECEIPT MAILED
Jan 20, 2026 MAFR
NEW APPLICATION ENTERED
Jan 20, 2026 NWAP